The Technology Development Board (TDB), under the Department of Science and Technology, has signed an agreement to provide ₹86 crore in financial supp
Read More
Drugs & VaccinationsHealth CareMedical
Scientists devise new strategy for combating fungal eye infection
India has a huge agrarian population, which is very prone to vegetative trauma while farming.Vegetative trauma to the eye is generally caused by infec
Read More
Drugs & VaccinationsMedicalNews from CommunityNews from Researchers
IIT Delhi launches economical Rapid Antigen Test Kit for COVID-19
Minister of State for Education Shri Sanjay Dhotre launched a Rapid Antigen Test kit for COVID-19 developed by IIT Delhi. The Rapid Antigen Test kit h
Read More
DNADrugs & VaccinationsLife SciencesMedicalMolecular & Cellular
Cryo-EM facilities can help research in structural biology, enzymology & drug discovery to combat new & emerging diseases
Researchers in the country would soon have access to four Cryogenic-Electron microscopy (Cryo-EM) facilities paving the way towards establishment of l
Read More
India Science Wire: An alcohol-free, aqueous, non-inflammable, and non-toxic hand sanitizer has been developed by a Pune-based start-up that will soon
Read More
CSIR-Indian Institute of Chemical Technology Hyderabad, a constituent laboratory of Council of Scientific and Industrial Research (CSIR) and Anthem Bi
Read More
Drugs & VaccinationsMedicalNews from CommunityNews from Labs
New drug for coronary diseases could be in offing
Council of Scientific and Industrial Research (CSIR)’s Lucknow-based constituent laboratory Central Drug Research Institute (CDRI) and Marc Laboratori
Read More
Drugs & VaccinationsHealth CareMedical
DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9
ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may
Read More
Drugs & VaccinationsMedical
CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19
CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment of
Read More
Drugs & VaccinationsHealth CareLife SciencesMedical
DBT-ILS establishes Animal Challenge Study Platform
COVID-19 is causing a major global pandemic. The scientific and clinical community are actively engaged to develop effective preventions and treatment
Read More